Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Free Report) – Seaport Res Ptn lowered their Q4 2024 earnings per share (EPS) estimates for shares of Curaleaf in a research note issued on Sunday, November 17th. Seaport Res Ptn analyst S. Randhawa now expects that the company will post earnings per share of ($0.08) for the quarter, down from their previous forecast of ($0.06). The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Seaport Res Ptn also issued estimates for Curaleaf’s Q1 2025 earnings at ($0.06) EPS, Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.05) EPS and FY2025 earnings at ($0.21) EPS.
Several other brokerages also recently issued reports on CURLF. Needham & Company LLC reiterated a “buy” rating and issued a $6.25 target price on shares of Curaleaf in a research note on Thursday, August 8th. Roth Capital upgraded shares of Curaleaf to a “strong-buy” rating in a research report on Sunday, November 10th. Finally, Cormark lowered shares of Curaleaf from a “moderate buy” rating to a “hold” rating in a report on Thursday, November 7th.
Curaleaf Stock Up 1.0 %
CURLF stock opened at $2.10 on Wednesday. The company has a market cap of $1.36 billion, a price-to-earnings ratio of -7.22 and a beta of 0.86. The company has a quick ratio of 0.51, a current ratio of 1.11 and a debt-to-equity ratio of 0.85. The business has a 50 day moving average price of $2.84 and a two-hundred day moving average price of $3.61. Curaleaf has a twelve month low of $1.64 and a twelve month high of $6.40.
About Curaleaf
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Further Reading
- Five stocks we like better than Curaleaf
- What Are Dividend Achievers? An Introduction
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- There Are Different Types of Stock To Invest In
- Williams-Sonoma Stock: Buy It and Never Let It Go
- The Significance of Brokerage Rankings in Stock Selection
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.